Substituted piperidines as novel mdm2-p53 inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 211/52 (2006.01) A61K 31/451 (2006.01) A61P 35/00 (2006.01) C07D 211/96 (2006.01)

Patent

CA 2516145

The present invention provides compounds having formula (II) or formula (III) and the pharmaceutically acceptable salts thereof; wherein X, n, and R1-R12 are defined herein. The invention also provides a pharmaceutical composition comprising a therapeutically effective amount of a compound represented by formula (II) or (III) and a pharmaceutically acceptable carrier or excipient. The compounds are useful for treating cancer.

L'invention concerne des composés de formule (II) ou de formule (III), ainsi que leurs sels pharmaceutiquement acceptables. X, n et R¿1?-R¿12? sont définis dans la présente. L'invention concerne également une composition pharmaceutique comprenant une quantité efficace sur le plan thérapeutique d'un composé représenté par la formule (II) ou la formule (III) et un support ou un excipient pharmaceutiquement acceptable. Lesdits composés s'utilisent dans le traitement du cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Substituted piperidines as novel mdm2-p53 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted piperidines as novel mdm2-p53 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted piperidines as novel mdm2-p53 inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1594999

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.